Showing results (31-40 of 115) with videos related to

Sort By:
Pageof 12
BMC Gastroenterology|February 10, 2022
Extremity risk factors of sepsis for gastrointestinal endoscopy in patients with liver cirrhosisYi-Chia Chan, Chao-Long Chen, Chih-Chi Wang, et al.
Antibodies (Basel, Switzerland)|January 22, 2024
Immune Responses to Anti-Hepatitis C Virus Antibodies during Pre-Liver Transplantation Direct-Acting Antiviral Therapy in Hepatitis C Virus-Infected Recipients Associated with Post-Liver Transplantation Allograft InjuryShu-Hsien Lin, Kun-Ta Wu, Chih-Chi Wang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 24, 2018
Genetic polymorphisms of the hepatic pathways of fatty liver disease after living donor liver transplantationKing-Wah Chiu, Shigeru Goto, Toshiaki Nakano, et al.
Biomed Research International|April 25, 2018
Identification of IL-28B Genotype Modification in Hepatocytes after Living Donor Liver Transplantation by Laser Capture Microdissection and Pyrosequencing AnalysisKing-Wah Chiu, Toshiaki Nakano, Kuang-Den Chen, et al.
BMC Gastroenterology|June 12, 2012
Comparison of argon plasma coagulation in management of upper gastrointestinal angiodysplasia and gastric antral vascular ectasia hemorrhageYi-Chun Chiu, Lung-Sheng Lu, Keng-Liang Wu, et al.
Transplantation|May 23, 2014
Section 13. Short-course pretransplant antiviral therapy is a feasible and effective strategy to prevent hepatitis C recurrence after liver transplantation in genotype 2 patientsChih-Che Lin, Catherine Kabiling, Chao-Long Chen, et al.
Annals of Transplantation|December 25, 2010
Influence of CYP2C19 genotypes on graft pathological findings and postoperative liver function in recipients after living-donor liver transplantationKing-Wah Chiu, Toshiaki Nakano, Tsung-Hui Hu, et al.
Antiviral Therapy|April 24, 2012
A novel experience of antiviral therapy for chronic hepatitis B in renal transplant recipientsTsung-Hui Hu, Ming-Chao Tsai, Yu-Shu Chien, et al.
Transplantation|May 23, 2014
Section 14. Combination of entecavir plus low-dose on-demand hepatitis B immunoglobulin is effective with very low hepatitis B recurrence after liver transplantationTsung-Hui Hu, Chao-Long Chen, Chih-Che Lin, et al.
The Journal of International Medical Research|August 4, 2021
HCV RNA in serum and liver samples of patients undergoing living donor liver transplantationShu-Hsien Lin, Kun-Ta Wu, Chih-Chi Wang, et al.
Pageof 12